YANTAI LNC BIOTECHNOLOGY SINGAPORE

Innovative Nuclear Medicine Development Platform Provider

Basic

Enterprise Profile

Basic Information

YANTAI LNC BIOTECHNOLOGY SINGAPORE PTE. LTD. is a wholly-owned subsidiary of Yantai Dongcheng Pharmaceutical Group. As Dongcheng Group's unique innovative nuclear medicine development platform, YANTAI LNC BIOTECHNOLOGY SINGAPORE is dedicated to the innovation of radiopharmaceutical diagnostics and therapeutics.

 YANTAI LNC BIOTECHNOLOGY SINGAPORE PTE. LTD.

 Singapore

 unclear

 --

 --

 cczhi@dcb-group.com

Enterprise Profile

Industrial Sector

New Drug Development Manufacture of Chemical Pharmaceutical Preparations

Concept

Tumor Therapeutic Products Department of Radiology

Application Scenarios

Chemical Drug Innovative Drugs